Environmental Influence on T-Cell Leukemia: Role of Notch and AhR Signaling

环境对 T 细胞白血病的影响:Notch 和 AhR 信号传导的作用

基本信息

  • 批准号:
    7448173
  • 负责人:
  • 金额:
    $ 9.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-01 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant) The purpose of this proposal is to facilitate the transition of Dr. Michael Laiosa from a mentored postdoctoral research position to an independent academic research scientist. In pursuit of the goal of establishing independence, Dr. Laiosa has proposed to translate findings from human epidemiological studies to a murine model of dioxin-induced T-cell leukemia. This murine model will be used to determine the underlying mechanism(s) of the environmental basis for T-cell acute lymphoblastic leukemia (T-ALL) formation and progression. The relevance to public health is that this model will be employed for a pre-clinical evaluation of the dietary and chemopreventative agent resveratrol, which has the potential to prevent the initiation and/or recurrence of T-cell leukemia in individuals with elevated cancer risk. Moreover, approximately 208,000 people in the United States are currently living with leukemia and approximately 22,000 people a year will die from the disease. Dozens of genetic risk factors for leukemic diseases have been identified, and a number of environmental agents have been shown to increase cancer risk, including 2,3,7,8 -tetrachlordibenzo-pdioxin (TCDD) and dioxin-like compounds, which humans are exposed to at low levels on a daily basis. Understanding, how environmental factors affect the development and progression of leukemia not only represents a significant gap in our knowledge but will also provide Dr. Laiosa with additional training in a new field for him (leukemia) using his extensive experience in the field of thymocyte development and developmental immunotoxicology as a framework. Specifically, this proposal will attempt to define how TCDD interacts with mutations in the Notch protein potentially leading to T-ALL. Mutations in Notch have been identified in more than 70% of patients with T-ALL. This proposal will determine how TCDD activation of the Aryl hydrocarbon receptor (AHR) potentially modulates Notch activity by testing the following three specific aims: 1) test the hypothesis that during thymocyte development, ligand activation of the AHR synergizes with the Notch protein, modulating gene expression, cell cycle regulation, and apoptotic regulation; 2) test the hypothesis that AHR expression and/or activation by environmental agents interacts with activated Notch" 1 promoting T-leukemeogenesis; 3) test the hypothesis that the chemo-preventative agent resveratrol antagonizes AHR dependent toxicity and inhibits T-ALL leukemeogenesis.
描述(由申请人提供) 这项提议的目的是促进Michael Laiosa博士从一个有导师的博士后研究职位过渡到一名独立的学术研究科学家。为了追求建立独立性的目标,莱奥萨博士提议将人类流行病学研究的结果转化为二恶英诱导的T细胞白血病的小鼠模型。这个小鼠模型将被用来确定T细胞急性淋巴细胞白血病(T-ALL)形成和发展的环境基础的潜在机制(S)。与公共健康相关的是,该模型将用于对饮食和化学预防药物白藜芦醇进行临床前评估,白藜芦醇有可能防止癌症风险较高的个人发生和/或复发T细胞白血病。此外,美国目前约有20.8万人患有白血病,每年约有2.2万人死于这种疾病。已确定了数十种白血病疾病的遗传风险因素,一些环境因素已被证明会增加癌症风险,包括2,3,7,8-四氯二苯并-二恶英(TCDD)和二恶英类化合物,人类每天都会低水平地接触到这些化合物。了解环境因素如何影响白血病的发展和进展,不仅是我们知识上的一个重大缺口,而且将为莱奥萨博士提供他在胸腺细胞发育和发育免疫毒理学领域的丰富经验作为框架的一个新领域的额外培训。具体地说,这项提案将试图定义TCDD如何与可能导致T-ALL的Notch蛋白突变相互作用。在超过70%的T-ALL患者中发现了Notch突变。这项建议将确定TCDD激活芳香烃受体(AHR)如何通过测试以下三个特定目标潜在地调节Notch的活性:1)检验在胸腺细胞发育过程中,AHR的配体激活与Notch蛋白协同作用、调节基因表达、细胞周期调节和细胞凋亡调节的假说;2)测试AHR的表达和/或环境因素激活与激活的Notch“1相互作用”的假说;3)测试化学预防性药物白藜芦醇拮抗AHR依赖毒性和抑制T-ALL白血病发生的假说。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael D Laiosa其他文献

Michael D Laiosa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael D Laiosa', 18)}}的其他基金

Regulation of metabolism by the Aryl hydrocarbon receptor in hematopoietic and immune cell progenitors
芳基烃受体对造血和免疫细胞祖细胞代谢的调节
  • 批准号:
    10353238
  • 财政年份:
    2021
  • 资助金额:
    $ 9.72万
  • 项目类别:
Regulation of metabolism by the Aryl hydrocarbon receptor in hematopoietic and immune cell progenitors
芳基烃受体对造血和免疫细胞祖细胞代谢的调节
  • 批准号:
    10538613
  • 财政年份:
    2021
  • 资助金额:
    $ 9.72万
  • 项目类别:
Environmental Influence on T-Cell Leukemia: Role of Notch and AhR Signaling
环境对 T 细胞白血病的影响:Notch 和 AhR 信号传导的作用
  • 批准号:
    8048544
  • 财政年份:
    2010
  • 资助金额:
    $ 9.72万
  • 项目类别:
Environmental Influence on T-Cell Leukemia: Role of Notch and AhR Signaling
环境对 T 细胞白血病的影响:Notch 和 AhR 信号传导的作用
  • 批准号:
    8265985
  • 财政年份:
    2010
  • 资助金额:
    $ 9.72万
  • 项目类别:
Environmental Influence on T-Cell Leukemia: Role of Notch and AhR Signaling
环境对 T 细胞白血病的影响:Notch 和 AhR 信号传导的作用
  • 批准号:
    8076899
  • 财政年份:
    2010
  • 资助金额:
    $ 9.72万
  • 项目类别:
Environmental Influence on T-Cell Leukemia: Role of Notch and AhR Signaling
环境对 T 细胞白血病的影响:Notch 和 AhR 信号传导的作用
  • 批准号:
    7660533
  • 财政年份:
    2008
  • 资助金额:
    $ 9.72万
  • 项目类别:

相似海外基金

Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
  • 批准号:
    20K08723
  • 财政年份:
    2020
  • 资助金额:
    $ 9.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
  • 批准号:
    9047400
  • 财政年份:
    2015
  • 资助金额:
    $ 9.72万
  • 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
  • 批准号:
    319114
  • 财政年份:
    2014
  • 资助金额:
    $ 9.72万
  • 项目类别:
    Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
  • 批准号:
    8595788
  • 财政年份:
    2013
  • 资助金额:
    $ 9.72万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8023518
  • 财政年份:
    2011
  • 资助金额:
    $ 9.72万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8404025
  • 财政年份:
    2011
  • 资助金额:
    $ 9.72万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8220724
  • 财政年份:
    2011
  • 资助金额:
    $ 9.72万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8599754
  • 财政年份:
    2011
  • 资助金额:
    $ 9.72万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8356701
  • 财政年份:
    2010
  • 资助金额:
    $ 9.72万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8166720
  • 财政年份:
    2009
  • 资助金额:
    $ 9.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了